Catecholaminergic pathway involved in angiotensin II-induced vasopressin release.
Veltmar
A
A
Department of Pharmacology, University of Heidelberg, Germany.
Qadri
F
F
Culman
J
J
Rascher
W
W
Unger
T
T
D000317:Adrenergic alpha-Antagonists / Q000494:pharmacology; D000804:Angiotensin II / Q000494:pharmacology*; D000818:Animals; D004146:Dioxanes / Q000494:pharmacology; D019329:Idazoxan; D007267:Injections; D008297:Male; D010286:Paraventricular Hypothalamic Nucleus / Q000378:metabolism; D011224:Prazosin / Q000494:pharmacology; D051381:Rats; D011919:Rats, Inbred Strains; D011942:Receptors, Adrenergic, alpha / Q000502:physiology*; D014667:Vasopressins / Q000378:metabolism*
D000317:Adrenergic alpha-Antagonists; D004146:Dioxanes; D011942:Receptors, Adrenergic, alpha; D014667:Vasopressins; D000804:Angiotensin II; D011224:Prazosin; D019329:Idazoxan